Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials-Reference-Cited by-同舟云学术

Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials

Published:2019-06 Issue:6 Volume:48 Page:958-966
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Tarp Simon^ORCID,Jørgensen Tanja S.,Furst Daniel E.,Dossing Anna,Taylor Peter C.,Choy Ernest H.^ORCID,Suarez-Almazor Maria E.,Lyddiatt Anne,Kristensen Lars E.,Bliddal Henning,Christensen Robin^ORCID

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference53 articles.

1. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2010

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017

3. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Rheumatol,2016

4. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study;Heiberg;Arthritis Rheum,2008

5. Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British society for rheumatology biologics register;Soliman;Ann Rheum Dis,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis;RMD Open;2024-08

2. Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review);Safety and Risk of Pharmacotherapy;2024-04-27

3. Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial;The Lancet Rheumatology;2024-02

4. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17

5. The use of methotrexate in rheumatoid arthritis. Recommendations of the All-Russian public organization “Association of Rheumatologists of Russia”;Rheumatology Science and Practice;2023-08-31